STOCK TITAN

Criteo S.A. Form 4 Filings

CRTO NASDAQ

Every Form 4 that Criteo S.A. (CRTO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRTO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRTO filings page.

Rhea-AI Summary

Criteo S.A. (CRTO) reported that Chief Legal Officer Damon Ryan sold 1,079 Ordinary Shares on September 1, 2026 at $17.50 per share. According to the company’s disclosure, these shares were automatically sold on his behalf to fund tax withholding obligations from the settlement of a previously reported equity award, leaving him with 163,765 shares held directly.

Rhea-AI Summary

Criteo S.A. (CRTO) disclosed that Chief Financial Officer Connor McGogney sold 276 Ordinary Shares on September 1, 2026 at $17.50 per share. According to the company’s disclosure, these shares were automatically sold to cover tax withholding obligations from the settlement of a prior equity award, and McGogney now holds 185,353 Ordinary Shares directly.

Rhea-AI Summary

Criteo S.A. (CRTO) director Stefanie Jay reported an acquisition of 6,200 Ordinary Shares on August 31, 2026, at a reported price of $17.72 per share, bringing her directly held position to 10,644 shares. The acquisition was made using additional remuneration under Criteo’s independent director compensation program, which must be used within a set period to purchase company securities on the open market and is subject to a time-based shareholding commitment agreed to by the director. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Criteo S.A. (CRTO) reported that Chief Legal Officer Damon Ryan sold 789 Ordinary Shares on 2026-08-28 at a price of $17.28 per share. According to the disclosure, these shares were automatically sold on his behalf to fund tax withholding obligations from the settlement of a previously reported equity award. Following this transaction, he held 164,844 Ordinary Shares directly.

Rhea-AI Summary

Criteo S.A. (CRTO) reported that CEO and director Michael Komasinski had 1,656 Ordinary Shares sold on 2026-08-28 at $17.28 per share. According to the disclosure, these shares were automatically sold to fund tax withholding obligations arising from settlement of a previously reported equity award, leaving him with 343,891 shares held directly.

Rhea-AI Summary

Criteo S.A. (CRTO) reported that its Chief Financial Officer, Connor McGogney, sold 258 Ordinary Shares on 2026-08-28 at $17.28 per share. According to the filing, these shares were automatically sold to fund tax withholding obligations from the settlement of a prior equity award. After this transaction, McGogney directly holds 185,629 Ordinary Shares.

Rhea-AI Summary

Criteo S.A. (CRTO) reported an insider transaction by Chief Financial Officer Connor McGogney. On 2026-08-24, McGogney had 671 Ordinary Shares sold at $17.37 per share. A footnote states these shares were automatically sold to cover tax withholding obligations from the settlement of a previously reported equity award, leaving McGogney with 185,887 Ordinary Shares held directly.

Rhea-AI Summary

Criteo S.A. (CRTO) reported that its Chief Legal Officer, Damon Ryan, had 2,132 Ordinary Shares sold on 2026-08-24 at a price of $17.37 per share. According to the disclosure, these shares were automatically sold on his behalf to fund tax withholding obligations from the settlement of a previously reported equity award. Following this transaction, he directly held 165,633 Ordinary Shares of Criteo.

Rhea-AI Summary

McGogney Connor reported acquisition or exercise transactions in this Form 4 filing.

Criteo S.A. reported that Chief Financial Officer Connor McGogney received a grant of 23,090 Ordinary Shares on August 10, 2026. The award is subject to time-based vesting: 25% vests on the one-year anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following 36 months. After this award, McGogney directly holds 186,558 Ordinary Shares.

Rhea-AI Summary

Criteo S.A. reported that Chief Financial Officer Sarah JS Glickman had 6,285 Ordinary Shares sold on her behalf on August 6, 2026 at $17.23 per share. A footnote states the shares were automatically sold to fund tax withholding obligations from settlement of a previously reported equity award, leaving her with 424,612 shares held directly.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported the sale of 6,178 Ordinary Shares on August 6, 2026 at $17.23 per share. The shares were automatically sold to fund tax withholding obligations from settlement of a prior equity award, and Ryan now directly holds 167,765 shares.

Rhea-AI Summary

Criteo S.A. CEO Michael Komasinski reported an automatic sale of 15,559 ordinary shares on August 6, 2026 at $17.23 per share, executed to fund tax withholding obligations arising from settlement of a previously reported equity award. Following the sale, he directly holds 345,547 ordinary shares.

Rhea-AI Summary

Criteo S.A. director Ernst Teunissen reported a same-day disposition to the issuer and compensatory acquisition of 12,471 Ordinary Shares on July 29, 2026, both at a stated price of 0.0000 per share. These entries relate to Criteo’s conversion from a French to a Luxembourg public limited liability company, in which each Ordinary Share and ADS continued as one Ordinary Share and existing equity awards continued on equivalent terms. A footnote also corrects his previously reported beneficial holdings upward by 3 shares due to a rounding error. The Rule 10b5-1 trading-plan checkbox was not marked.

Rhea-AI Summary

Criteo S.A. Chief Financial Officer Sarah JS Glickman reported restructuring-related equity movements on July 29, 2026. She disposed of 430,897 Ordinary Shares in a disposition to the issuer and recorded a matching acquisition of 430,897 Ordinary Shares in connection with the company’s conversion from a French to a Luxembourg public limited liability company, with equity award rights otherwise remaining unchanged.

Rhea-AI Summary

Criteo S.A. reports that CEO Michael Komasinski recorded a disposition to the issuer of 361,106 Ordinary Shares and a matching grant of 361,106 Ordinary Shares on July 29 2026, each at 0.0000 per share, in connection with a corporate conversion.

On that date Criteo completed a shareholder-approved conversion from a French to a Luxembourg public limited liability company. Each Ordinary Share, including those represented by ADSs, and each related equity award continued on a one-for-one basis, with rights unchanged apart from now referencing Luxembourg shares.

Rhea-AI Summary

Criteo S.A. director Rachel Picard reported two non-derivative transactions on July 29, 2026 in connection with the company’s conversion from a French to a Luxembourg public limited liability company. She disposed of 53,488 Ordinary Shares to the issuer at 0.0000 per share and, the same day, recorded a grant or other acquisition of 53,488 Ordinary Shares, also at 0.0000 per share. Footnotes explain that each Ordinary Share and related ADS, restricted stock unit, option and warrant continued on a one-for-one basis in the new Luxembourg entity, with award rights otherwise unchanged, and that the filing does not characterize these transactions as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Damon Ryan, Chief Legal Officer of Criteo S.A., reported paired equity movements tied to the company’s corporate conversion to a Luxembourg entity. On July 29 2026 he returned 173,943 Ordinary Shares to the issuer for no consideration, then received a matching 173,943-share award in the new Luxembourg company, with award rights continuing unchanged.

Rhea-AI Summary

On July 29, 2026, Criteo S.A. director Nathalie Balla reported a structural reclassification of 33,846 Ordinary Shares, disposing them to the issuer at $0.00 per share and receiving an equivalent number in connection with Criteo’s conversion from a French to a Luxembourg public limited liability company, with ADSs and equity awards continuing on a one-for-one basis and no net change in her reported share count.

Rhea-AI Summary

Director Edmond Mesrobian reported two related movements in Criteo S.A. ordinary shares on July 29, 2026. He disposed of 32,187 ordinary shares to the issuer and on the same date acquired 32,187 ordinary shares at 0.00 per share, in connection with Criteo’s conversion from a French to a Luxembourg public limited liability company, with equity awards continuing as awards over Lux Criteo shares.

Rhea-AI Summary

Criteo S.A. director Marie Lalleman reported two matching entries on July 29, 2026 tied to the company’s legal conversion from a French to a Luxembourg public limited liability company. She recorded a disposition to the issuer of 42,736 Ordinary Shares and a corresponding acquisition of 42,736 Ordinary Shares. Footnotes explain that, in this Conversion, each Ordinary Share of French Criteo (including any represented by American Depositary Shares) continued as one Ordinary Share of Lux Criteo, and all related RSU, PSU, option and warrant awards continued on the same terms but now settle in Lux Criteo shares.

Rhea-AI Summary

Criteo S.A. director Jay Stefanie reported two non-derivative movements of ordinary shares on July 29, 2026. A disposition of 4,444 shares to the issuer and a matching 4,444-share grant, each at $0.0000 per share, are described in footnotes as part of Criteo’s one-for-one conversion from a French to a Luxembourg public limited liability company.

Rhea-AI Summary

Criteo S.A. completed a corporate conversion on July 29, 2026, changing from a French to a Luxembourg public limited liability company while keeping equity terms intact. In connection with this Conversion, director Frederik van der Kooi recorded a technical disposition of 26,600 Ordinary Shares of the French entity to the issuer and a matching acquisition of 26,600 Ordinary Shares of the new Luxembourg entity, both at no cost, reflecting the one-for-one continuation of equity interests through the Conversion. Each Ordinary Share, including those previously represented by American Depositary Shares, as well as existing time-based and performance-based restricted stock units, options and warrants, continued on a one-for-one basis into securities of the Luxembourg company.

Rhea-AI Summary

Criteo S.A. Chief Financial Officer Sarah JS Glickman reported an automatic sale of 982 Ordinary Shares on 2026-06-01 at $18.50 per share. The shares were sold on her behalf to cover tax withholding obligations from the settlement of a previously reported equity award.

After this transaction, she directly held 430,897 Ordinary Shares, so the tax-related sale represents only a small portion of her disclosed holdings. Each Ordinary Share may be represented by an American Depositary Share, with each ADS currently equal to one Ordinary Share.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported an automatic sale of 1,079 Ordinary Shares at $18.50 per share. According to the disclosure, these shares were sold to cover tax withholding obligations from the settlement of a previously reported equity award. After this transaction, Ryan directly holds 173,943 Ordinary Shares, indicating that the sale represents a small portion of his overall reported holdings. The company notes that its Ordinary Shares may also be held in the form of American Depositary Shares, each representing one Ordinary Share.

Rhea-AI Summary

Criteo S.A. Chief Financial Officer Sarah JS Glickman reported the automatic sale of 2,465 Ordinary Shares on 2026-05-26 at $17.06 per share. According to the disclosure, these shares were sold on her behalf to fund tax withholding obligations from the settlement of a previously reported equity award. After these transactions, she directly holds 431,879 Ordinary Shares, which may be represented by American Depositary Shares on a one-for-one basis.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported the automatic sale of 2,132 Ordinary Shares of Criteo on May 26, 2026 in open-market transactions at $17.06 per share. According to the footnotes, these shares were sold on his behalf solely to fund tax withholding obligations from the settlement of a prior equity award, rather than as a discretionary sale. After these transactions, he continues to hold more than 175,000 Criteo Ordinary Shares directly.

Rhea-AI Summary

Criteo S.A. director Frederik van der Kooi reported an open-market purchase of 5,000 Ordinary Shares. The shares were bought at an average price of $17.81 per share, increasing his direct holdings to 26,600 Ordinary Shares. The filing notes these Ordinary Shares may also be held as American Depositary Shares.

Rhea-AI Summary

Criteo S.A. reported that its Chief Legal Officer, Damon Ryan, received a grant of 63,259 Ordinary Shares as equity compensation. The award was recorded at a price of $0.00 per share, indicating a share grant rather than an open‑market purchase. Following this transaction, Ryan directly holds 177,154 Ordinary Shares.

The shares are subject to time-based vesting. Under the primary schedule, 25% vests on the one-year anniversary of the grant date, with the remainder vesting quarterly over the next 36 months. If the company’s conversion into a Luxembourg entity is not completed before the first anniversary, 50% will instead vest on the two-year anniversary, with the balance vesting quarterly over the following two years.

Rhea-AI Summary

Criteo S.A. reported that Chief Financial Officer Sarah JS Glickman received a grant of 83,502 Ordinary Shares as equity compensation. The grant price was $0.00 per share. After this award, she directly holds 434,344 Ordinary Shares.

The shares vest over time: initially 25% on the one-year anniversary of the grant and the remainder quarterly over the following 36 months. If the company’s conversion into a Luxembourg company is not completed before the first anniversary, 50% instead vests on the two-year anniversary, with the balance vesting quarterly over the following two years.

Rhea-AI Summary

Criteo S.A. CEO Michael Komasinski reported an equity award of 141,700 Ordinary Shares, received as a grant with no purchase price. Following this award, he directly holds 361,106 Ordinary Shares. The shares vest over time: 25% on the one-year anniversary of the grant and the remainder in equal quarterly installments over the next 36 months.

If the company’s planned conversion into a Luxembourg company is not completed before the first anniversary of the grant date, the vesting schedule shifts so that 50% vests on the two-year anniversary and the remaining 50% vests in equal quarterly installments over the following two years.

Rhea-AI Summary

Criteo S.A. Chief Financial Officer Sarah JS Glickman reported automatic sales of a total of 20,247 Ordinary Shares in open-market transactions. The sales included 1,943 shares at $18.48 per share on March 3, 2026 and 18,304 shares at $17.99 per share on March 2, 2026. According to the filing, these shares were sold automatically to fund tax withholding obligations from the settlement of a previously reported equity award, and she continued to hold over 350,000 shares after the transactions.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported automatic sales of company Ordinary Shares to fund tax withholding obligations from an equity award settlement. On March 2, 2026, he sold 13,385 shares at $17.99 each, and on March 3, 2026, he sold 1,509 shares at $18.48 each, for total reported sales of 14,894 shares. After these open-market sales, he directly holds 113,895 Ordinary Shares, which may be represented by American Depositary Shares on a one-for-one basis.

Rhea-AI Summary

Criteo S.A. reported that Chief Financial Officer Sarah JS Glickman acquired ordinary shares through equity awards, with no cash paid per share. On February 26, 2026, 17,284 shares became eligible for time-based vesting from performance-based stock units granted on February 28, 2025. Two thirds of these shares will vest on the two-year anniversary of that grant date, and the remainder on the three-year anniversary.

On the same date, 4,915 additional shares became eligible for time-based vesting from a performance-based stock unit grant made on March 1, 2024. These 4,915 shares are scheduled to vest on the two-year anniversary of that earlier grant. Following these acquisitions, Glickman directly owned 371,089 ordinary shares. The ordinary shares may be represented by American Depositary Shares, each currently representing one ordinary share.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported equity awards tied to performance-based stock units. On February 26, 2026, he acquired 13,093 Ordinary Shares at a price of $0.00 per share following achievement of performance goals from a February 28, 2025 grant. He also acquired 4,165 Ordinary Shares at $0.00 per share from the first performance tranche of a March 1, 2024 grant. After these award-related acquisitions, his direct holdings totaled 128,789 Ordinary Shares, which may be represented by American Depositary Shares on a one-for-one basis.

Rhea-AI Summary

Criteo S.A. CEO Michael Komasinski reported an equity award tied to prior performance goals. He acquired 42,771 ordinary shares at no cost following the determination of the performance achievement on February 26, 2026. These shares will vest over two and three years from the February 28, 2025 grant date.

Rhea-AI Summary

Criteo S.A. Chief Financial Officer Sarah JS Glickman reported automatic sales of company stock to cover taxes from an equity award. On February 23, 2026, she sold 2,796 Ordinary Shares at $16.81 per share. On February 24, 2026, she sold 1,541 Ordinary Shares at $16.71 per share. The filing states these shares were automatically sold on her behalf to fund tax withholding obligations from the settlement of a previously reported security award. Following these transactions, she directly owns 348,890 Ordinary Shares, which may be represented by American Depositary Shares, each currently equal to one Ordinary Share.

Rhea-AI Summary

Criteo S.A. Chief Legal Officer Damon Ryan reported automatic sales of company stock to cover tax obligations from equity awards. On February 23, he sold 1,736 ordinary shares at $16.81 per share, and on February 24, he sold 1,019 shares at $16.71 per share. After these tax-related sales, he continued to hold 111,531 ordinary shares. Each ordinary share may also be represented by one American Depositary Share.

Rhea-AI Summary

Criteo S.A. director Rachel Picard reported buying additional company stock. On 12/12/2025, she acquired 8,276 Ordinary Shares at a price of $20.63 per share, bringing her total beneficial ownership to 53,488 Ordinary Shares held directly.

The filing explains that these shares were purchased under a compensation plan for non-employee directors, where additional remuneration must be used within a set period to buy Criteo securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the director. The Ordinary Shares may also be held as American Depositary Shares, with each ADS currently representing one Ordinary Share.

Rhea-AI Summary

Criteo S.A. (CRTO) reported an insider transaction by its Chief Financial Officer, Sarah Glickman. On 11/24/2025, she sold 3,982 Ordinary Shares at a price of $19.51 per share. The filing explains these shares were automatically sold to cover tax withholding obligations from the settlement of a previously reported equity award, rather than a discretionary open-market sale. After this transaction, she beneficially owns 353,227 Ordinary Shares, which may be held directly or in the form of American Depositary Shares, each currently representing one Ordinary Share.

Rhea-AI Summary

Criteo S.A. (CRTO) reported an insider transaction by its Chief Legal Officer. On 11/24/2025, the reporting person sold 3,394 Ordinary Shares at a price of $19.51 per share. After this transaction, the reporting person beneficially owned 117,508 Ordinary Shares.

The filing explains that these shares were automatically sold to cover tax withholding obligations that arose from the settlement of a previously reported equity award. The Ordinary Shares may be represented by American Depositary Shares, each representing one Ordinary Share.

Rhea-AI Summary

Criteo S.A. (CRTO) reported an insider transaction on a Form 4 by its Chief Legal Officer. On 11/13/2025, the officer reported a sale of 6,444 ordinary shares, executed in multiple transactions at prices ranging from $24.06 to $26.12 per share. Following the transaction, the officer beneficially owned 120,902 shares, held directly. The filing notes that Criteo’s ordinary shares may be represented by ADSs, with each ADS equal to one ordinary share.

Rhea-AI Summary

Criteo S.A. (CRTO) disclosed that a company director reported acquiring 4,444 ordinary shares on 11/05/2025. The filing notes these were open‑market purchases made under the issuer’s independent director compensation program, which provides additional remuneration that must be used to buy company securities and is subject to a time‑based shareholding commitment.

The purchases occurred in multiple transactions at prices ranging from $22.18 to $22.51 per share. Following the reported transactions, the director directly holds 4,444 shares. The ordinary shares may be represented by ADSs, with each ADS currently representing one ordinary share.

Rhea-AI Summary

Criteo S.A. (CRTO) disclosed an insider share purchase by a company director. On 11/10/2025, the reporting person bought 5,000 Ordinary Shares at a price of $21.52 per share, coded as a P (open-market or private purchase). Following this transaction, the individual directly owns 21,600 Ordinary Shares.

The filing notes that Criteo’s Ordinary Shares may be represented by American Depositary Shares, with each ADS currently representing one Ordinary Share. The report was filed by one reporting person and reflects direct (D) ownership after the transaction.

Rhea-AI Summary

Criteo (CRTO) reported an insider transaction by director Marie Lalleman. On 11/10/2025, she acquired 2,437 ordinary shares at a $21.78 weighted average price, with individual trade prices ranging from $21.46 to $21.98.

The purchase was made under the company’s independent director compensation program, which provides additional remuneration to be used for open‑market share purchases and is subject to a time‑based shareholding commitment. After this transaction, Lalleman beneficially owns 42,736 shares, held directly.

Rhea-AI Summary

Criteo S.A. (CRTO) director reported an open‑market purchase of 6,450 Ordinary Shares on 11/04/2025 at a price of $22.61 per share. Following this transaction, the director beneficially owns 33,846 Ordinary Shares.

The purchase was made under the company’s independent director compensation program, which provides additional remuneration that must be used within a set period to buy company securities on the open market. These shares are subject to a time‑based shareholding commitment. Each ADS currently represents one Ordinary Share.

Rhea-AI Summary

Criteo S.A. (CRTO) director Marie Lalleman reported buying 3,833 ordinary shares on November 3, 2025 at a $22.69 weighted average price (transactions ranged from $22.37 to $22.80). The purchase was made under the company’s independent director compensation plan and is subject to a time-based shareholding commitment.

After this transaction, Lalleman beneficially owns 40,299 shares, held directly. American Depositary Shares each represent one ordinary share.

Rhea-AI Summary

Criteo S.A. (CRTO) reported insider purchases by a director on 11/03/2025. The director acquired 6,177 Ordinary Shares at a weighted average price of $22.65 under the company’s independent director compensation program, which requires using additional remuneration to purchase shares and includes a time-based shareholding commitment. A separate open-market purchase added 4,403 shares at $22.71. Following these transactions, the director beneficially owned 12,468 shares. Each ADS currently represents one Ordinary Share.

Rhea-AI Summary

Criteo S.A. (CRTO) reported insider activity by director Frederik van der Kooi. On 11/03/2025, he acquired 7,701 ordinary shares at $22.61 under the company’s independent director compensation plan and separately purchased 2,299 shares at $22.61. After these transactions, he beneficially owned 16,600 shares, held directly. The plan provides additional remuneration that must be used to buy company shares and includes a time-based shareholding commitment. Each ADS currently represents one ordinary share.

Rhea-AI Summary

Criteo S.A. reported an insider share purchase. A director acquired 6,172 Ordinary Shares on 11/03/2025 at $22.73 per share. Following the transaction, the director directly owns 32,187 Ordinary Shares.

The filing notes that Ordinary Shares may be represented by American Depositary Shares, each currently representing one Ordinary Share. The purchase was made under the company’s independent director compensation program, which provides additional remuneration that must be used within a set period to buy company securities on the open market, subject to a time-based shareholding commitment.